Asymptomatic screening for SARS CoV-2 prior to commencement of biologic therapies in patients with inflammatory bowel disease - a potentially harmful practice. Issue 11 (November 2020) - Prentice, Ralley E.; Al-Ani, Aysha H; Bond, Katherine; Johnson, Doug; Christensen, Britt